Exciting updates from our content and strategy team
April 23, 2025 |
Cuttsy+Cuttsy celebrates new beginnings with the appointment of Oli Bailey as Strategy Director and recognises team excellence through several well-deserved promotions.
As we usher in the new financial year, we are pleased to welcome a new Strategy Director to Cuttsy+Cuttsy and celebrate the accomplishments of our talented team members through some well-deserved promotions.
At the beginning of the month, we welcomed Oli Bailey as our new Strategy Director. As Strategy Director, Oli brings a critical perspective to Cuttsy+Cuttsy, guiding our approach to develop impactful solutions that resonate with our clients and the patients and communities we support. Oli carries a wealth of experience in healthcare communications, that will be invaluable to our team as we continue to grow and evolve.
Speaking about joining the team, Oli shared, “I’m incredibly excited to join such a talented and passionate group of individuals. It’s clear that this agency is driven by a commitment to creating work that truly matters, and I can’t wait to get started on helping to shape the strategy that will keep us at the forefront of healthcare communications.”
But that’s not all! We also had some amazing growth within our Content and Strategy team this month. We’re proud to announce several well-deserved promotions that highlight the hard work, passion, and dedication of our talented colleagues:
Scott Palmer: promoted to Principal Patient Writer
Beth Bhuva: promoted to Principal Medical Writer
Katie Breen: promoted to Senior Patient Writer
These promotions are a testament to their commitment to creating content that truly makes a difference in people’s lives. Their efforts have consistently raised the bar, and we couldn’t be prouder of their achievements. Congratulations to all three of them on these exciting milestones!
Here’s to a month of growth, new beginnings, and well-earned recognition. We’re excited for what the future holds for the team and look forward to seeing their continued impact.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
How is generative AI transforming clinical trials?
Discover how generative AI is revolutionising clinical trials, from enhancing patient recruitment to improving data analysis.
Content for all – how to connect with neurodiverse audiences
Discover essential strategies for crafting inclusive and accessible written content tailored for neurodivergent readers.
Cuttsy+Cuttsy launches ccura: AI powered, always human
Cuttsy+Cuttsy introduces ccura, an AI-powered healthcare communications platform that blends technology with human expertise to enhance collaboration, streamline workflows, and deliver patient-focused, high-quality solutions with security and compliance at its…
Two Sides of the Same Coin: Patient Engagement vs Patient Involvement
Unpack the difference between patient engagement and patient involvement.
Cuttsy+Cuttsy achieves Platinum accreditation from Investors in People
Cuttsy+Cuttsy is proud to have achieved a Platinum accreditation from Investors in People, placing them among the top 2% of organisations assessed globally.
Cuttsy+Cuttsy awarded Gold EcoVadis sustainability rating
Cuttsy+Cuttsy proudly announces their Gold Medal achievement from EcoVadis for 2024, placing them among the top 5% of companies assessed and within the 97th percentile, a testament to their unwavering…
Age is not just a number when it comes to clinical trials
In this blog we look at the critical underrepresentation of older adults in clinical trials, emphasising the need for inclusive trial designs and targeted strategies to ensure safe and effective…
How to boost clinical trial access and make patients health-empowered
Clinical research is becoming more patient-centric, but there’s still more that needs to be done to make clinical trials available to everyone. This could include wider participation.
Closing the loop: Why clinical trial results matter to participants
Discover why sharing clinical trial results with participants is crucial for respect, informed health decisions, and fostering strong researcher-participant partnerships.
Unveiling the truth: A journey into women’s representation in clinical trials
We explore the historical exclusion of women from clinical trials, its consequences on medical research and treatment efficacy and the ongoing efforts to ensure their representation.